Cancer Advances, Inc. Announces Issuance of New U.S. Patent

DURHAM, N.C., Feb. 28, 2023 (GLOBE NEWSWIRE) — Cancer Advances, Inc., a clinical stage biopharmaceutical company developing therapeutics for gastrointestinal…

Related Keywords

Canada , Toronto , Ontario , Lynda Sutton , Trademark Office , Postmedia Network Inc , Cancer Advances Inc , Cancer Advances , Announces Issuance , Polyclonal Antibody Stimulator , Inducing Humoral , Cellular Immunities , Postmedia Network , Street East , Antibody Stimulator ,